Also called: MD
Important: This page is general information, not medical advice. It does not recommend or prescribe any treatment. Always consult your doctor or pharmacist before starting, stopping or changing any medicine.
About Muscular Dystrophy
Muscular dystrophy (MD) is a group of more than 30 genetic diseases. They cause weakness of the muscles. Over time, the weakness gets worse and can cause trouble walking and doing daily activities. Some types of MD can also affect other organs.
There are many different types of MD. Some of the more common types include:
- Duchenne muscular dystrophy, which is the most common childhood form. It is severe and affects boys more often than girls. The symptoms usually start between ages 3 and 6.
- Becker muscular dystrophy, which is similar to Duchenne but is less severe and gets worse more slowly. It often starts in the teenage years.
- Congenital muscular dystrophies, which are present at birth or before age 2. They can be mild or severe.
- Facioscapulohumeral muscular dystrophy, which often starts in the teenage years. At first, it affects the muscles of the face, shoulders, and upper arms.
Each of the types of MD can be different in many ways, such as:
- Who is more likely to get them
- Which muscles they affect
- When they appear, such as in infancy, childhood, middle age, or later
- What the symptoms are
- How serious the symptoms are
- How quickly they get worse
- Whether they run in families
- Whether they affect other organs
Even within the same type of MD, people can have different symptoms.
MD is genetic, meaning that it caused by a change in one or more genes. Gene changes are also called gene variants or mutations. The gene changes in MD affect proteins that strengthen and protect muscles.
There are different gene changes that cause each type of MD. And sometimes people who have the same type of MD can have different gene changes.
Muscular dystrophy can run in families, or you can be the first in your family to have a muscular dystrophy.
To find out if you or your child has MD, your health care provider may use:
- A medical and family history
- A physical exam
- Blood and urine tests, including genetic tests and tests for certain enzymes that may be released by damaged muscles
- Muscle biopsies
- Electromyography and nerve conduction studies to find out if muscles are responding the right way to nerve signals
- Heart testing, such as an electrocardiogram (EKG), since some types of MD can cause heart problems
- Exercise tests to measure muscle strength and breathing and detect any increased rates of certain chemicals following exercise
- Imaging tests such as an MRI to look at muscle quality and bulk and measure fatty replacement of muscle tissue
There is no cure for muscular dystrophy. Treatment can help with the symptoms and prevent complications. It usually includes a combination of therapies, such as:
- Physical therapy to help keep muscles flexible and strong
- Occupational therapy to relearn lost motor skills and learn ways to work around weakened muscles
- Respiratory care, such as breathing exercises, oxygen therapy, and ventilators
- Speech therapy to help with speech and swallowing problems
- Assistive devices, such as wheelchairs, splints and braces, and walkers
- Medicines to help delay damage to muscles or minimize the symptoms of MD
- Surgery to treat some of the conditions associated with MD, such as heart problems, scoliosis, and cataracts
It sits within Bones, Joints and Muscles and Genetics/Birth Defects.
The lead U.S. institute for this subject is the National Institute of Neurological Disorders and Stroke.
When to speak to someone. Reading about a topic cannot tell you whether it applies to you. Speak to a doctor or pharmacist if symptoms are severe, sudden, getting worse, or simply not going away — and seek emergency care immediately for chest pain, breathing difficulty, sudden weakness or confusion, or a serious allergic reaction.
Research on Muscular Dystrophy
896 studies areregistered for this condition on ClinicalTrials.gov, the U.S. National Library of Medicine's public registry. A selection is below — the links go straight to the registry entry, not to a summary of ours.
What a registered study does and does not mean. Registration means a study exists and has been declared publicly. It says nothing about whether the treatment being tested works, is safe, or is available to you. Many studies find no benefit — that is what research is for. Never seek out an experimental treatment on the strength of a registry entry alone.
Research currently under way
- Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1Dyne Therapeutics
- Skeletal Muscle Biomarkers in People With Fragile Sarcolemmal Muscular DystrophyEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Managed Access Program for Del-zota in Participants With DMD Mutations Amenable to Exon 44 SkippingAvidity Biosciences, Inc.
- Ph2 Open-label Study of AOC 1044 in Duchenne Muscular Dystrophy Participants With Mutations Amenable to Exon44 SkippingAvidity Biosciences, Inc.
- A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1PepGen Inc
- Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug TrialsVanderbilt University Medical Center
Research already completed
- CureDuchenne Link®: A Resource for ResearchCureDuchenne
Study data from ClinicalTrials.gov, a service of the U.S. National Library of Medicine. Retrieved 2026-07-30. Registry entries are supplied by study sponsors and investigators; ClinicalTrials.gov does not verify their scientific validity. PocketsInfo is not affiliated with, and not endorsed by, the NLM or the NIH.
Where to read more
Rather than paraphrase, we point you to the primary sources. Every link below is to a government health agency, a national institute or a recognised medical body — grouped by what you are trying to find out.
Start Here
- About Muscular DystrophyCenters for Disease Control and Prevention
- Muscular DystrophyMayo Foundation for Medical Education and Research
- Muscular DystrophyNational Institute of Neurological Disorders and Stroke
- Muscular Dystrophy (For Parents)Nemours Foundation
Diagnosis and Tests
- Creatine KinaseNational Library of Medicine
- Electromyography (EMG) and Nerve Conduction StudiesNational Library of Medicine
- How Is Muscular Dystrophy (MD) Diagnosed?Eunice Kennedy Shriver National Institute of Child Health and Human Development
Treatments and Therapies
- Medications and Supplements (Other Than Steroids)Parent Project for Muscular Dystrophy Research
Living With
- Daily Living ResourcesParent Project for Muscular Dystrophy Research
- Learning and BehaviorParent Project for Muscular Dystrophy Research
- Muscular Dystrophy: Other FAQsEunice Kennedy Shriver National Institute of Child Health and Human Development
Genetics
- About Duchenne Muscular DystrophyNational Human Genome Research Institute
- About Myotonic DystrophyNational Human Genome Research Institute
- CAV3-related distal myopathy: MedlinePlus GeneticsNational Library of Medicine
- Distal myopathy 2: MedlinePlus GeneticsNational Library of Medicine
- Duchenne and Becker muscular dystrophy: MedlinePlus GeneticsNational Library of Medicine
- Emery-Dreifuss muscular dystrophy: MedlinePlus GeneticsNational Library of Medicine
- Fukuyama congenital muscular dystrophy: MedlinePlus GeneticsNational Library of Medicine
- Laing distal myopathy: MedlinePlus GeneticsNational Library of Medicine
- LAMA2-related muscular dystrophy: MedlinePlus GeneticsNational Library of Medicine
- Limb-girdle muscular dystrophy: MedlinePlus GeneticsNational Library of Medicine
Statistics and Research
- Data Summary: Muscular DystrophyCenters for Disease Control and Prevention
Clinical Trials
- ClinicalTrials.gov: Muscular DystrophiesNational Institutes of Health
- ClinicalTrials.gov: Muscular Dystrophy, DuchenneNational Institutes of Health
Medical subject headings
Clinicians and researchers index this subject under Muscular Dystrophies. These are the terms to use when searching medical literature.
This page is built from the MedlinePlus health topic record for Muscular Dystrophy, a service of the U.S. National Library of Medicine (NLM), National Institutes of Health. Information is from MedlinePlus.gov. PocketsInfo is not affiliated with, and is not endorsed by, the NLM or the NIH. Retrieved 30 July 2026.